1. Rapid remission with calcipotriol betamethasone in refractory Fox–Fordyce disease
- Author
-
Tao Wang, Lu Yang, Tanja Prunk Zdravković, Zhixin He, Shiyu Zhang, and Yuehua Liu
- Subjects
Adult ,medicine.medical_specialty ,Fox–Fordyce disease ,Umbilicus (mollusc) ,Fox-Fordyce Disease ,Dermatology ,Hair Removal ,Betamethasone ,030207 dermatology & venereal diseases ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Calcitriol ,medicine ,Humans ,Calcipotriol ,business.industry ,Apocrine ,General Medicine ,medicine.disease ,Perineum ,body regions ,Axilla ,medicine.anatomical_structure ,chemistry ,030220 oncology & carcinogenesis ,Etiology ,Female ,business ,medicine.drug - Abstract
Fox-Fordyce disease (FFD) is a rare pruritic dermatosis whose etiology has not been fully explored. It is mostly seen in women and presents as pruritic follicular papules at the apocrine (gland-bearing) regions, including the axilla, groins, perineum, and areola mammae, as well as the umbilicus. Treatment for FFD is extremely challenging in that there is no curative treatment for it. We report the case of a 26-year-old woman who was refractory to many treatments but who responded to calcipotriol betamethasone with rapid remission of her symptoms.
- Published
- 2020